IRD compared with LQDA: revenue, margins and what each company keeps, and the suppliers and customers both name

IRDOpus Genetics, Inc.

Mkt capRevenueRevenue

LQDALiquidia Corp

Mkt capRevenueRevenue

Compare

IRDOpus Genetics, Inc.

LQDALiquidia Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

IRD1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±41.2%▼−1.59%×0.04

LQDA

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±11.9%▼−10.52%×0.88

May 11 '26±12.0%▲+25.60%×2.13

= impliedIRD realized, solidLQDA realized, hatchedOne scale, both sides: full bar = 42%× = |realized| ÷ impliedSource: market data

Q1 FY26

±13.8%

▲+0.41%

×0.03

Q3 FY25±30.8%▲+3.53%×0.11

IRDOpus Genetics, Inc.

4.17▲+4.11%· post 4.17

Mkt cap$347.8MRevenue$755,000Q2 FY26Revenue$14MFY25

LQDALiquidia Corp

44.44▼−0.12%· post 44.41

ClosedNov 6 '26

Mkt cap$4.5BRevenue$172MQ2 FY26Revenue$158MFY25

Compare

ClosedNov 6 '26

IRDOpus Genetics, Inc.

LQDALiquidia Corp

4.17▲+4.11%post 4.17

Price

44.44▼−0.12%post 44.41

$347.8M

Mkt cap

$4.5B

Q2 FY26$755,000

Revenue

$172MQ2 FY26

FY25$14M

Revenue

$158MFY25

IRD4.17▲+4.11%vsLQDA44.44▼−0.12%ClosedNov 6 '26